Meet the Expert: Demis N. Lipe

January 30, 2024

Meet the Expert: Demis N. Lipe

 

Our "Meet the Expert" series introduces you to our team of experts around the world. This "behind the curtain" view will help you get to know who we are on a professional and personal level, and highlight how our colleagues work together on our higher purpose to improve patient health and safety throughout the complete product lifecycle.

Meet Demis N. Lipe, Senior Medical Director

Demis N. Lipe will be speaking at the 2024 Oncologic Emergency Medicine Conference held at the MD Anderson Cancer Center in Houston, TX. She will be discussing the latest updates on immunotherapy and CAR-T therapy. For more information, visit the 2024 Oncologic Emergency Medicine Conference and the LinkedIn Event page.

What do you like best about working with clients? 

I enjoy working with clients because it allows me to apply my medical expertise collaboratively. I find satisfaction in understanding their specific requirements, tailoring our approach to meet their objectives, and providing valuable insights. Building strong relationships with clients enhances the overall project success and allows me to contribute meaningfully to their goals through effective communication and strategic support.

What do you do at ProPharma? How does your role support improving the health and safety of patients?

In my role at ProPharma as a Senior Medical Director, I provide functional oversight to medical monitors, support business development in various aspects such as proposal development, and collaborate on projects that directly impact patient outcomes. By overseeing medical monitoring activities, I contribute to the early detection of potential issues, ensuring that patient safety is prioritized throughout the drug development process. Additionally, my involvement in proposal development allows me to provide meaningful feedback on studies and interventions that are not only scientifically sound but also to give meaningful feedback on studies and interventions that are scientifically sound and prioritize patient well-being. Ultimately, my role revolves around aligning our efforts with the highest standards of medical practices, thereby supporting and improving the health and safety of patients in every aspect of our work at ProPharma.

What is one lesson you’ve learned in this industry that has most helped you?

I've learned that fostering open communication channels and embracing transparency are pivotal lessons in our industry. Clients entrust us with the responsibility of running their studies, and what I've found to be most valued is our commitment to clear and honest collaboration. By prioritizing transparent communication, we also build trust and ensure that our clients are well-informed every step of the way. This dedication to openness defines our approach at ProPharma setting the foundation for successful partnerships and contributing to the advancement of patient-centric and impactful clinical research. Another lesson I have learned is the value of being nimble and solution-oriented. Clients appreciate our ability to navigate challenges swiftly, offering tailored solutions that keep their studies on track. In a dynamic environment, adaptability is not just an asset; it's a commitment to ensuring success.

Tell us about a day in the life of a Senior Medical Director.

As a Senior Medical Director at ProPharma, each day unfolds as a dynamic blend of responsibilities, reflecting the multifaceted nature of our growing organization. My role is comprehensive, from providing strategic oversight to hands-on involvement in medical monitoring, study management, safety assessments, client strategy or early engagement meetings,  and beyond. I wear many hats to ensure our studies' success and the department's continuous growth. Whether it's guiding the team with strategic insights or diving into the intricacies of day-to-day operations, I am dedicated to doing whatever it takes to foster excellence and contribute to the success of our studies and the overall advancement of our department. Every day brings new challenges, and I embrace them with enthusiasm and commitment.

What’s one thing you’d like potential clients to know about ProPharma?

ProPharma redefines the traditional CRO model by offering tailored solutions prioritizing the client’s success. Our agile and flexible approach is what makes us different. It ensures that we adapt to the client’s unique needs, reducing delays and driving consistency throughout the project's life. We place clients at the center to maximize the probability of success.

 

TAGS:

August 20, 2018

FDA Drafts List of Device Accessories to be Reclassified into Class I

On Thursday, August 16th, the FDA released a list of medical device accessories that have the potential to be reclassified as class I devices. Background According to section 513 of the Food, Drug, &...

January 20, 2016

Cybersecurity in Medical Devices: Definitions from FDA's Draft Guidance

Compensating Controls: “A safeguard or countermeasure, external to the device, employed by a user in lieu of, or in the absence of sufficient controls that were designed in by a device manufacturer,...

August 15, 2022

FDA Pathways to Medical Device Approval

Commercializing your medical device in the US market often requires submitting a marketing application to the FDA to become an FDA Approved or Cleared Medical Device. The content of your FDA...